BiotechTV
2,440 posts
BiotechTV
@BiotechTV
Daily biotech news, content, and exclusive interviews.
𝐅𝐫𝐨𝐦 𝐂𝐚𝐦𝐛𝐫𝐢𝐝𝐠𝐞, 𝐔𝐊: PlaqueTec Ltd.'s has a unique liquid biopsy system and multi omic analysis approach that aims to profile the underlying biology of atherosclerosis. Full video: biotechtv.com/post/plaquetec…
00:00- 𝐅𝐫𝐨𝐦 𝐋𝐮𝐧𝐝: @AsgardThx aims to turn tumor cells into a type of dendritic cell inside the body with that the immune system can learn the tumor's signature and fight it systemically. Full video: biotechtv.com/post/asgard-th…
00:00 - 𝐅𝐫𝐨𝐦 𝐋𝐮𝐧𝐝: Lund based BioInvent has had a busy week with a presentation of one program in ovarian cancer at ASCO, and two more coming up in hematological cancers at the upcoming EHA Congress. Full video: biotechtv.com/post/bioinvent…
00:00 - 𝐌&𝐀 𝐍𝐞𝐰𝐬: Biotech woke up to a $10.6 billion deal today. GSK will be acquiring the targeted cancer company Nuvalent. $NUVL
00:00 - 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Cambridge, UK based Cyclana Bio aims to find a cure for endometriosis through a deep understanding of human biology and the extracellular matrix. With Co-Founder & CEO @lea_md_wenger. Full video: biotechtv.com/post/cyclana-b…
00:00 - 𝐁𝐞𝐡𝐢𝐧𝐝 𝐭𝐡𝐞 𝐒𝐜𝐞𝐧𝐞𝐬: Engitix Therapeutics scientist Amy Lewis gave BiotechTV a behind-the-scenes look today at the science behind the company's extracellular matrix (ECM) discovery platform. The company announced a collaboration with GSK this morning.
00:00 - 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: GSK and London based Engitix Therapeutics announced today they will collaborate on first in class targets for liver fibrosis regression using Engitix's extracellular matrix (ECM) discovery platform. Full video: biotechtv.com/post/engitix-t…
00:00 - 𝐉𝐮𝐧𝐞 𝟖: Here's a summary of the most important news in biotech this morning.
- 𝐔.𝐒. 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟔: BiotechTV is organizing a summit in Kendall Square on July 21 to discuss how to correct the narrative on scientfic innovation in the U.S. and beyond. Join us - let's celebrate science and discuss how we can get more people behind it.
00:00 - 𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: @AstraZeneca CEO Pascal Soriot discusses the company's new Kendall Square R&D Center that will be opening in September/October. There will be 3,000 scientists working there.
00:00 
00:00
